Do Not Add Another Calcium Channel Blocker
In a patient already taking lisinopril 40 mg and amlodipine with a resting heart rate ≤60 bpm or significant conduction disease, you should NOT add or substitute another calcium channel blocker. Instead, optimize the current regimen or add a different antihypertensive class.
Why This Matters
The patient is already on amlodipine, a dihydropyridine calcium channel blocker (CCB). The critical issue here is the resting heart rate ≤60 bpm or conduction disease, which creates specific contraindications:
Contraindications for Non-Dihydropyridine CCBs
Diltiazem and verapamil are absolutely contraindicated in this scenario 1, 2. These non-dihydropyridine CCBs:
- Avoid routine use with beta blockers because of increased risk of bradycardia and heart block 1, 2
- Prolong AV node conduction and can cause significant bradycardia 3, 4, 5
- Should be avoided in patients with existing bradycardia (heart rate <60 bpm) or any degree of heart block 6
- Have prominent AV and sinus node effects that would worsen pre-existing conduction abnormalities 3
Problems with Adding More Dihydropyridines
Adding another dihydropyridine CCB (like felodipine, nifedipine) to existing amlodipine provides:
- No additional benefit on heart rate or conduction (dihydropyridines have minimal AV/sinus node effects) 3, 7
- Redundant mechanism of action
- Increased risk of dose-related peripheral edema, which is already common with amlodipine 1, 2
- Potential for excessive vasodilation and hypotension
What to Do Instead
First: Optimize Current Therapy
- Ensure lisinopril is at maximum dose (already at 40 mg - this is the maximum) 1, 2
- Assess amlodipine dose - can be increased from 2.5-10 mg daily if blood pressure control is inadequate and patient tolerates it 1, 2
Second: Add a Thiazide Diuretic
Add chlorthalidone 12.5-25 mg daily or hydrochlorothiazide 25-50 mg daily 1, 2. This is the preferred next step because:
- Chlorthalidone is preferred based on prolonged half-life and proven CVD reduction 1, 2
- Thiazide diuretics are primary agents for hypertension 1, 2
- No negative effects on heart rate or conduction - safe with bradycardia
- Synergistic with ACE inhibitors
- Monitor for hypokalemia, hyponatremia, and uric acid elevation 1, 2
Third: Consider Aldosterone Antagonists
If blood pressure remains uncontrolled after adding a thiazide:
Add spironolactone 25-100 mg daily or eplerenone 50-100 mg daily 1, 2. These are:
- Preferred agents in resistant hypertension 1, 2
- Common add-on therapy when three-drug regimens fail 1, 2
- No effect on heart rate or conduction
- Monitor potassium closely (risk of hyperkalemia with ACE inhibitor) - avoid if K+ >5.0 mmol/L or GFR <30-45 mL/min 1, 2
Critical Pitfalls to Avoid
Never use diltiazem or verapamil in patients with heart rate ≤60 bpm or conduction disease - this will worsen bradycardia and can precipitate high-degree AV block 1, 2, 6
Do not use beta-blockers - while not CCBs, they would also worsen bradycardia and are contraindicated with heart rate <50-60 bpm 4, 8
Avoid combining non-dihydropyridine CCBs with beta-blockers - synergistic negative effects on heart rate and conduction 9, 10
Monitor for heart block - if the patient develops symptomatic bradycardia or any degree of AV block, arrange ECG and consider cardiology referral 8
Evidence Supporting This Approach
The 2017 ACC/AHA Hypertension Guidelines clearly state that non-dihydropyridine CCBs should "avoid routine use with beta blockers because of increased risk of bradycardia and heart block" 1, 2. While the patient isn't on a beta-blocker, the same concern applies to pre-existing bradycardia or conduction disease.
Amlodipine, in contrast, "does not change sinoatrial nodal function or atrioventricular conduction" and "did not alter electrocardiographic intervals or produce higher degrees of AV blocks" even when combined with beta-blockers 7. However, adding more of the same class provides no additional benefit.
The guideline-recommended approach for resistant hypertension is sequential addition of different drug classes: ACE inhibitor/ARB + CCB + thiazide diuretic, then adding an aldosterone antagonist if needed 1, 2.